TVARDI THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $50.7M | $12.1M |
| FY2017 | — | $86.8M | $9.4M |
| FY2018 | — | $133.6M | $15.1M |
| FY2019 | — | $186.7M | $18.3M |
| FY2020 | — | $249.0M | $31.7M |
| FY2021 | — | $227.5M | $13.5M |
| FY2022 | — | $158.8M | $63.7M |
| FY2023 | — | $-62.1M | $51.8M |
| FY2024 | — | $-91.1M | $31.6M |
| FY2025 | — | $20.9M | $20.7M |